Literature DB >> 22729334

Quinacrine induced mood disturbance--the unmasking of bipolar affective disorder.

John Lally1, Fintan Byrne, Elizabeth Walsh.   

Abstract

The authors report the case of a 20-year-old man who presented with a de novo episode of hypomania subsequent to the initiation of quinacrine for treatment resistant giardiasis. The hypomanic episode commenced some 20 days after the successful completion of a week long course of quinacrine 100 mg three times daily. The hypomanic episode was treated with olanzapine 10 mg daily. Two months subsequent to this, the patient developed a moderate depressive episode which was treated with escitalopram and olanzapine. One month after the resolution of the depressive episode, he once again presented with a hypomanic episode. The recurring episodes of discrete mood disturbance all occurred within 5 months of the commencement of quinacrine in an individual with no personal history of affective disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729334      PMCID: PMC3387445          DOI: 10.1136/bcr.02.2012.5842

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.

Authors:  P J Barrett; P D Emmins; P D Clarke; D J Bradley
Journal:  BMJ       Date:  1996-08-31

2.  Quinacrine-induced psychiatric disturbances in a child with common variable immunodeficiency and chronic giardiasis.

Authors:  Ferah Genel; Serpil Erermis; Guzide Aksu; Can Ozturk; Necil Kutukculer
Journal:  Hum Psychopharmacol       Date:  2002-10       Impact factor: 1.672

3.  Acute psychosis after mefloquine. Report of six cases.

Authors:  A Sowunmi; R A Adio; A M Oduola; O A Ogundahunsi; L A Salako
Journal:  Trop Geogr Med       Date:  1995

4.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

Review 5.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 6.  Mefloquine neurotoxicity: a literature review.

Authors:  Stephen Toovey
Journal:  Travel Med Infect Dis       Date:  2009-01-14       Impact factor: 6.211

Review 7.  Giardiasis. Issues in diagnosis and management.

Authors:  D R Hill
Journal:  Infect Dis Clin North Am       Date:  1993-09       Impact factor: 5.982

8.  Psychotic mania associated with mefloquine in a bipolar patient.

Authors:  Meredith Brumbaugh; Paul Price; Nancy Fagan; Hudson Hsieh
Journal:  South Med J       Date:  2008-05       Impact factor: 0.954

9.  Toxic psychosis following use of quinacrine.

Authors:  J P Lindenmayer; P Vargas
Journal:  J Clin Psychiatry       Date:  1981-04       Impact factor: 4.384

10.  Pharmacokinetics of quinacrine in the treatment of prion disease.

Authors:  Lotus Yung; Yong Huang; Pierre Lessard; Giuseppe Legname; Emil T Lin; Michael Baldwin; Stanley B Prusiner; Chongsuk Ryou; B Joseph Guglielmo
Journal:  BMC Infect Dis       Date:  2004-11-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.